Catarina Resende de Oliveira
#122,296
Most Influential Person Now
Portuguese neurologist
Catarina Resende de Oliveira's AcademicInfluence.com Rankings
Catarina Resende de Oliveiramedical Degrees
Medical
#3575
World Rank
#4053
Historical Rank
Neurology
#330
World Rank
#423
Historical Rank

Catarina Resende de Oliveiraphilosophy Degrees
Philosophy
#13048
World Rank
#18309
Historical Rank
Logic
#10155
World Rank
#12996
Historical Rank

Download Badge
Medical Philosophy
Catarina Resende de Oliveira's Degrees
- Doctorate Neurology University of Lisbon
- PhD Neuroscience University of Porto
Why Is Catarina Resende de Oliveira Influential?
(Suggest an Edit or Addition)According to Wikipedia, Catarina Resende de Oliveira is a Portuguese neurologist, researcher, university professor, and doctor. A full professor of biochemistry at the Faculty of Medicine of the University of Coimbra, she studies the processes that cause neurological degeneration responsible for illnesses such as Alzheimer's disease and Parkinson's disease.
Catarina Resende de Oliveira's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. (2015) (1112)
- Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP (2010) (209)
- DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA (2008) (196)
- Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment (2007) (140)
- Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia (2017) (121)
- Association of Cerebral Amyloid-&bgr; Aggregation With Cognitive Functioning in Persons Without Dementia (2018) (116)
- Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal (2009) (110)
- Brief Report: High Frequency of Biochemical Markers for Mitochondrial Dysfunction in Autism: No Association with the Mitochondrial Aspartate/Glutamate Carrier SLC25A12 Gene (2006) (105)
- Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease (2012) (102)
- Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment (2017) (100)
- G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort (2005) (99)
- Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview. (2008) (90)
- Assessment of fight outcome is needed to activate socially driven transcriptional changes in the zebrafish brain (2016) (89)
- Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort (2006) (86)
- Lack of replication of association between GIGYF2 variants and Parkinson disease. (2008) (65)
- Genetic Variability in CLU and Its Association with Alzheimer's Disease (2010) (61)
- Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2 (2008) (52)
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease (2017) (52)
- Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship. (2006) (51)
- Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment (2018) (50)
- Transthyretin decrease in plasma of MCI and AD patients: investigation of mechanisms for disease modulation. (2012) (47)
- NO and HNO donors, nitrones, and nitroxides: Past, present, and future (2018) (41)
- miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease (2020) (39)
- ABCA7 p.G215S as potential protective factor for Alzheimer's disease (2016) (38)
- Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study (2015) (32)
- Novel progranulin mutation: Screening for PGRN mutations in a Portuguese series of FTD/CBS cases (2008) (30)
- Proactive response to tackle the threat of emerging drugs: Synthesis and toxicity evaluation of new cathinones. (2018) (29)
- Prognosis of Early-Onset vs. Late-Onset Mild Cognitive Impairment: Comparison of Conversion Rates and Its Predictors (2016) (22)
- Effect of Oxidative Stress on the Uptake of GABA and Glutamate in Synaptosomes Isolated from Diabetic Rat Brain (2000) (22)
- Development of an analytical methodology for simultaneous determination of vincristine and doxorubicin in pharmaceutical preparations for oncology by HPLC-UV. (2009) (20)
- Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics. (2016) (19)
- Decreased superoxide dismutase activity in erythrocytes from patients with Alzheimer's disease (1993) (15)
- Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers. (2018) (11)
- Linking brain stroke risk factors to human movement features for the development of preventive tools (2014) (8)
- Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration. (2018) (8)
- Mitochondrial DNA Variants in a Portuguese Population of Patients with Alzheimer’s Disease (2005) (7)
- Parkinson’s Disease and Mitochondrial DNA NADH Dehydrogenase Subunit 1 Nucleotides 3337–3340: Study in a Population from the Central Region of Portugal (Coimbra) (2003) (6)
- Oxidative damage and mitochondrial dysfunction in patients with mild cognitive impairment and Alzheimer's disease (2010) (5)
- P1-348 Early onset familial Alzheimer’s disease: First Portuguese cases (2006) (3)
- Cerebrospinal fluid biomarkers in frontotemporal lobar degeneration (2011) (3)
- Study of blood and pubic hair mineralograms of alcoholic people (2013) (2)
- P1-349 Genetic analysis of Portuguese patients with Alzheimer’s disease and frontotemporal dementia (2006) (1)
- Reflexões (2021) (1)
- Usefulness of Liver and Spleen Acoustic Radiation Force Impulse (ARFI) for the evaluation of cirrhotic patients (2014) (1)
- Development of a biological recognition layer to universal binding for application in immunoassays (2013) (0)
- JAMA Paper supplement (2015) (0)
- Genes and Parkinson's disease - A clinic-based study in a Portuguese cohort (2006) (0)
- Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment (2018) (0)
- P4-253 Oxidative stress and antioxidant defenses in mild cognitive impairment and Alzheimer's disease (2004) (0)
- P4-208 Inflammation in mild cognitive impairment and mild Alzheimer's disease (2004) (0)
- Parkinson's disease and apolipoprotein E genotype: Possible association? (2005) (0)
- Memory decline and cerebrospinal fluid biomarkers in MCI (2011) (0)
This paper list is powered by the following services:
Other Resources About Catarina Resende de Oliveira
What Schools Are Affiliated With Catarina Resende de Oliveira?
Catarina Resende de Oliveira is affiliated with the following schools: